GSK3B and Alzheimer disease: In addition, amyloid-β oligomers were found to activate GSK-3β, blocking PI3K/AKT/mTOR signaling, which increases the phosphorylation of Tau, inducing neurofibrillary tangle formation, which is a pathophysiological hallmark in AD.